How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium
Mots clés
Abstrait
La description
With a complex etiology, delirium is usually caused by various peri-operative stimuli on basis of predisposing factors, including senility, hypoxia and hypotension, pain, drug (such as pethidine, benzodiazepine, anticholinergic, and drug withdrawal), complications prior to surgery, post-operative sleep disorder. As for the mechanism of delirium, the commonly accepted hypothesis includes the decreased central cholinergic neurons function and the inflammation of central nervous system. Most of the hip fracture patients are senile, suffering generally from many complications with exposure to many drugs, and poor in nutritional status with decreased cognitive function even before the surgery in some of them, all of which are risk factors for post-operative delirium. Systematic review suggests that incidence of POD in patients undergoing elective hip arthroplasty is up to 4-53.3%. It is of great importance, therefore, to explore the effective approaches to lower POD incidence in senile patients with operation on hip fracture.
Dexmedetomidine Hydrochloride is a novel highly-selective α2 adrenergic receptor agonist, and its selectivity to α2 receptor is 8 times of that of clonidine. It has multiple functions including sedation, anti-anxiety, hypnosis, analgesia and sympathetic blockade, with a wide application prospect for peri-operative patients. Researches suggest that Dex applied peri-operatively may stabilize blood pressure and heart rate, control intra-operative stress, and decrease post-operative side reactions such as nausea, vomiting, restlessness, delirium and chills. Moreover, advantages of Dex also include analgesia and reduction of opioid usage. Clinical pharmacological characteristics of Dex suggest its possible function to decrease post-operative delirium. Meanwhile, Dex seems to have a minor influence on cognition, since it has no effect on GABA receptor.
Another important feature of it is that Dex induces a sleep similar to natural sleep, thereby decreasing sleep deprivation and circadian rhythm disorder in post-operative patients, and decreasing incidence of post-operative delirium. Researches evaluating the capability of Dex to decrease delirium incidence are focused on ICU sedation post to operation. Riker et al compared the sedative effect between Dex and midazolam in patients with severe mechanical ventilation, revealing a lower delirium incidence in Dex than in midazolam (54.0% vs 76.6%) in patients maintained with the same depth of sedation. Systematic review concludes that Dex in effective to prevent and treat post-operative delirium in ICU patients.
In this study ,the investigators devise the two different sedatives (Dexmedetomidine and Propofol)'influence on postoperative delirium in hip fracture elderly participants under spinal anesthesia
Rendez-vous
| Dernière vérification: | 11/30/2017 |
| Première soumission: | 09/13/2017 |
| Inscription estimée soumise: | 11/13/2017 |
| Première publication: | 11/16/2017 |
| Dernière mise à jour soumise: | 12/10/2017 |
| Dernière mise à jour publiée: | 12/12/2017 |
| Date de début réelle de l'étude: | 12/31/2017 |
| Date d'achèvement primaire estimée: | 12/29/2018 |
| Date estimée d'achèvement de l'étude: | 06/29/2019 |
Condition ou maladie
Intervention / traitement
Drug: Dexmedetomidine Hydrochloride
Drug: Propofol
Phase
Groupes d'armes
| Bras | Intervention / traitement |
|---|---|
| Experimental: Dexmedetomidine Hydrochloride Dex Group: 0.5 μg/kg of Dex is given 10 minutes before operation through injection pump during 15 minutes. After the operation starts, the initial pumping ratio of Dex is 0.5ug/kg/h and adjusted under BIS surveillance to keep BIS between 70-80 until 30 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails. | Drug: Dexmedetomidine Hydrochloride Dexmedetomidine is given to patients during spinal anesthesia at the dose of 0.5 μg/kg，adjusted the dose to keep BIS between 70-80 until 30 minutes before the end of surgery |
| Active Comparator: Propofol Prop Group: Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts. Under BIS surveillance, dripping rate is adjusted to keep BIS between 70-80 until 5 minutes before the end of surgery. Meanwhile, OAA/S grade is evaluated every 15 minutes to maintain OAA/S at grade 4. If discrepancy occurs, OAA/S prevails. | Drug: Propofol Propofol is given with an initial ratio of 2-10mg/kg/h, when the operation starts，adjust the propofol`s dose to keep BIS between 70-80 before the end of surgery |
Critère d'éligibilité
| Âges éligibles aux études | 65 Years À 65 Years |
| Sexes éligibles à l'étude | All |
| Accepte les bénévoles en santé | Oui |
| Critères | Inclusion Criteria: 1. Acquisition of informed consent, 2. Patients with hip fracture surgery under lumbar anesthesia, 3. Grade II to III based on American Society of Anesthesiologists ASA classification, 4. Age ≥65 and ≤90 years old. Exclusion Criteria: 1. History of psychiatric disease or a disease needing long-term exposure to psychotropic drugs (dementia, schizophrenia), or history of alcoholic abuse. 2. More than 8 errors in preoperative Simplified Psychology and Mental Status Questionnaire (SPMSQ) , and diagnosed as severe cognitive impairment. 3. CAM positive diagnosed preoperatively. 4. Any cerebrovascular accident occurring within 3 months, such as cerebral stroke or transient ischemic attack (TIA). 5. Systolic pressure < 90mmHg and diastolic pressure < 60mm Hg at the preoperative follow up or HR< 50/minute. 6. History of heat failure or EF<30% as shown by ultrasound cardiogram; degree 2 type 2 and degree 3 atrioventricular block. History of active heart disease (such as acute cardiac infarction, unstable angina pectoris) 7. Severe abnormality in hepatic or renal function (severe abnormality in liver function: more than 2-times increase than upper normal limit in any one of the markers including ALT,, conjugated bilirubin, AST, ALP, total bilirubin; severe abnormality in renal function; Cr clearance<30ml/min), Scr>443μmol/L. 8. Diabetes patients with severe complications of diabetes (Diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular diseases, and diabetic nephropathy) 9. Patients with severe infection. 10. Postoperative PaO2<60mmHg or SpO2<92%. 11. Participation in clinical trials of other drugs within past 30 days. 12. Disturbed verbal communication, and unable to accomplish the test on cognition. 13. Patients with prosthesis fracture or restoration; hip fracture but complicated with severe trauma in other sites. 14. Being allergic to investigational drug or having contradiction of lumbar anesthesia. |
Résultat
Mesures des résultats primaires
1. occurrence of postoperative delirium in postoperative 72 hours [patient enrolled will be evaluated at 9Am and 3Pm during post-operative day 1-3 (POD1-3).At any time point above，delirium is detected，then the patient will be diagnosed as postoperative delirium. All patients enrolled is Non-delirium before surgery。]
Mesures des résultats secondaires
1. Consumption of analgesic [record the data of comsumption of analgeisic at 48 hours after operation]
2. Times of intra-operative occurrence of hypotension, bradycardia, hypertension and tachycardia that need treatment. [during the operation]
3. Score of quality of post-operative sleeping [quality of sleeping will be assessed at 9Am during post-operative day 1-3]
4. Hospital stay [record the days of hospital stay at the 30 days after surgery]
5. Post-operative complications besides delirium [observe and evaluate complications at the 30 days after surgery]
6. Mortality up to day 30 post to operation [the data will be collected after 30 days of operation]
7. pain score [Pain score will be evaluated at time point of operation, 1，6，24, 48 hours after operation, using NRS score]
